Vietnam Investment Review on MSN
Takeda's dengue vaccine wins India's first approval
NEW DELHI, July 21, 2026 /PRNewswire/ -- Takeda today announced that India's Drug Controller General of India (DCGI) has granted marketing authorization for Takeda's dengue vaccine (TAK-003) for the ...
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for India's first dengue vaccine, ...
ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...
CDC teams tracing the outbreak were gutted after DOGE cut USAID funding, and a scaled-back FoodNet program made illness ...
Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the 'Company” or 'Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary ...
The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past two decades[1]Takeda's dengue vaccine (TAK-003) is the most extensively ...
ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate ...
The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to leading domestic ...
On July 16, the launch ceremony of the event themed A Century of Legacy, A Future of Shared Prosperity – Commemorative ...
Cecilia Ramirez spends her summer crisscrossing the Oklahoma City area. She drives a van decorated with smiling cartoon kids ...
Public health agencies are urging continued vigilance regarding the Zika virus, a mosquito-borne illness that remains a ...
Japanese drugmaker Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results